Keywords: USA, Patent settlements, Pay-for-delay deals, Supreme Court review, FTC, Fitch Ratings

Pay-for-delay settlements court ruling could hurt drugmakers, says Fitch

Article | 30 July 2012

The possibility of a Supreme Court review regarding patent settlements, often dubbed "pay-for-delay" agreements, between brand-name and generic drug manufacturers ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in